Here's where our story gets good
Thanks to the ongoing generosity of our supporters - individuals, families, corporate partners and community organisations - we're making a difference.
Since 2007, we've funded 563 cancer projects, including some exceptionally talented scientists and brilliant researchers. The result? We've funded 70 significant cancer breakthroughs in research and care.
We're outsmarting cancer together
Cancer evolution is the single biggest challenge we face in creating better treatment for those affected. Although there have been some incredible advances in the fight against cancer, the disease is constantly evolving and finding new ways to resist the effects of therapy. That's why we're incredibly proud of the projects we've funded and what we've achieved so far. It's spurred us on to achieve even greater things.
For decades, surgery, radiation and chemotherapy have been the three staple treatments against cancer. But clinical trials in recent years have shown that harnessing the body’s immune response—which evolved to fend off harmful bacteria and viruses, among other things—presents a new treatment alternative. It's opened up a whole new frontier in the fight for a cure.
We're incredibly proud that thanks to your support, we've been able to fund 50 significant cancer breakthroughs - including breakthroughs in the area of immunology.
Meet Dr Christopher Chan
Dr Christopher Chan, a Project Leader at BioCurate in Melbourne, has had a long interest in harnessing the power of the immune system to fight cancer. He started out as a talented young researcher at the Peter MacCallum Cancer Centre in Melbourne, where funding from Tour de Cure enabled him to focus on immunology to fight leukaemia. In the course of his research, Dr Chan discovered some vital new leads on how to outwit this deadly disease. Dr Chan has gone on to continue his work as an immunologist in America. He recently contributed to defining the function of a new gene, which could inhibit the body's immune response to cancer and has helped to develop a new anti-body drug to reverse this. The drug is currently in development for clinical trials. Dr Chan is extremely grateful to Tour de Cure for backing him when he was an emerging researcher and enabling him to make such progress in the fight to cure and prevent cancer.
From pioneering research to late phase clinical trials
Nobody should have to go through cancer alone.
1 in 3 cancers are preventable.